Agents and Actions

, Volume 16, Issue 1–2, pp 58–59

The mechanism of the anti-inflammatory activity of glucocorticosteroids

  • S. J. Foster
  • M. E. McCormick
General Inflammation
  • 14 Downloads

References

  1. [1]
    G.J. Blackwell, R.J. Flower, F.P. Nijkamp andJ.R. Vane,Phospholipase A 2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids, Br. J. Pharmac.62, 79–89 (1978).Google Scholar
  2. [2]
    G.J. Blackwell, R. Carnuccio, M. Di Rosa R.J. Flower, L. Parente andP. Persico,Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature, Lond.287, 147–149 (1980).Google Scholar
  3. [3]
    F. Hirata, E. Schiffman, K. Venkatasubramanian, D. Salomon andJ. Axelrod,A phospholipase A 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids, Proc. natn. Acad. Sci. USA77, 2533–2536 (1980).Google Scholar
  4. [4]
    T.J. Williams,Prostaglandin E 2,prostaglandin I 2 and the vascular changes of inflammation, Br. J. Pharmac.65, 517–524 (1979).Google Scholar
  5. [5]
    D.S. Paterson, T.M. Twose, M.E. McCormick, A.E. Cunningham andS.J. Foster,Polymorphonuclear leukocyte accumulation in inflammatory dermal sites measured by a novel neutrophil specific marker protein, Sicth European Workshop on Inflammation, London, 26–27 March 1984.Google Scholar
  6. [6]
    G.A. Higgs,The effects of lipoxygenase inhibitors in anaphylactic and inflammatory responses in vivo, Prostaglandins, Leukotrienes and Medicine13, 89–92 (1984).CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag 1985

Authors and Affiliations

  • S. J. Foster
    • 1
  • M. E. McCormick
    • 1
  1. 1.Pharmaceuticals DivisionImperial Chemical Industries plcMacclesfieldUK

Personalised recommendations